{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:50:16Z","timestamp":1785307816189,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.clinbiochem.2022.04.013","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T01:42:26Z","timestamp":1651023746000},"page":"48-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Medical appropriateness and economics of nucleic acid amplification testing for infectious diseases"],"prefix":"10.1016","volume":"117","author":[{"given":"Shira","family":"Doron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2022.04.013_b0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM200101183440308","article-title":"Acute pharyngitis","volume":"344","author":"Bisno","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.clinbiochem.2022.04.013_b0010","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0015","unstructured":"CDC. Group A Streptococcal Disease. https:\/\/www.cdc.gov\/groupastrep\/diseases-hcp\/strep-throat.html (Accessed August 26, 2021)."},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.04.013_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01494-19","article-title":"Group A streptococcus testing in pediatrics: the move to point-of-care molecular testing","volume":"58","author":"Thompson","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"9979","key":"10.1016\/j.clinbiochem.2022.04.013_b0025","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.04.013_b0030","doi-asserted-by":"crossref","first-page":"e01281","DOI":"10.1128\/JCM.01281-18","article-title":"Clinical impact of rapid point-of-care PCR influenza testing in an urgent care setting: a single-center study","volume":"57","author":"Benirschke","year":"2019","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.04.013_b0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.04.013_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00083-21","article-title":"Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high-throughput drive-through community testing site in Massachusetts","volume":"59","author":"Pollock","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.714242","article-title":"Factors that influence the reported sensitivity of rapid antigen testing for SARS-CoV-2","volume":"12","author":"Parvu","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.04.013_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd5393","article-title":"Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening","volume":"7","author":"Larremore","year":"2021","journal-title":"Sci. Adv."},{"issue":"22","key":"10.1016\/j.clinbiochem.2022.04.013_b0055","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1056\/NEJMp2025631","article-title":"Rethinking Covid-19 test sensitivity \u2014 a strategy for containment","volume":"383","author":"Mina","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0060","article-title":"The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing","author":"Hanson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0065","unstructured":"The Philadelphia Inquirer. https:\/\/www.inquirer.com\/philly\/health\/health-costs\/flu-test-cost-400-20180412.html (Accessed August 26, 2021)."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0070","unstructured":"Huffington Post. https:\/\/www.huffpost.com\/entry\/cost-of-healthcare-becomi_b_12089840 (Accessed August 26, 2021)."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0075","unstructured":"CDC. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. https:\/\/www.cdc.gov\/infectioncontrol\/pdf\/guidelines\/isolation-guidelines. (Accessed November 21. 2021)."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0080","unstructured":"CDC. Sexually Transmitted Infections. Trichomoniasis. https:\/\/www.cdc.gov\/std\/trichomonas\/default.htm (Accessed November 21, 2021)."},{"key":"10.1016\/j.clinbiochem.2022.04.013_b0085","unstructured":"CDC. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. https:\/\/www.cdc.gov\/std\/treatment-guidelines\/screening-recommendations.htm (Accessed November 21, 2021) Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources."},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.04.013_b0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pathol.2020.07.008","article-title":"Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis","volume":"53","author":"Webb","year":"2021","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.04.013_b0095","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1016\/j.ijid.2013.07.011","article-title":"Performance of Anyplex\u2122 II multiplex real-time PCR for the diagnosis of seven sexually transmitted infections: comparison with currently available methods","volume":"17","author":"Choe","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.04.013_b0100","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/ijerph18031038","article-title":"Current and future trends in the laboratory diagnosis of sexually transmitted infections","volume":"18","author":"Caruso","year":"2021","journal-title":"Int. J. Environ. Res. Public Health."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:00:30Z","timestamp":1757865630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912022001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":20,"alternative-id":["S0009912022001163"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.04.013","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical appropriateness and economics of nucleic acid amplification testing for infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}